229 Avelumab combined with pegylated liposomal doxorubicin in platinum-resistant/refractory ovarian cancer: biomarker analyses from JAVELIN Ovarian 200

E Pujade-Lauraine; J Ledermann; A Oza; R Kristeleit; I Ray-Coquard; G Richardson; C Sessa; K Yonemori; S Banerjee; A Leary; X Mu; Y Liu; K Ching; S Deng; J Perkins Smith; A Donahue; K Fujiwara; B Monk

doi:10.1136/ijgc-2021-ESGO.361

Article info

Ovarian cancer

229 Avelumab combined with pegylated liposomal doxorubicin in platinum-resistant/refractory ovarian cancer: biomarker analyses from JAVELIN Ovarian 200

Free

Authors

E Pujade-Lauraine ARCAGY-GINECO, Paris, France PubMed articles Google scholar articles
J Ledermann UCL Cancer Institute, London, UK UCL Hospitals, London, UK PubMed articles Google scholar articles
A Oza Princess Margaret Cancer Centre, Toronto, Canada PubMed articles Google scholar articles
R Kristeleit UCL Cancer Institute, London, UK UCL Hospitals, London, UK PubMed articles Google scholar articles
I Ray-Coquard Centre Léon Bérard, Service de Cancérologie Médicale, Université Claude Bernard Lyon 1, Lyon, France GINECO, Lyon, France PubMed articles Google scholar articles
G Richardson Cabrini Hospital, Department of Medical Oncology, Bellinzona, Switzerland PubMed articles Google scholar articles
C Sessa Oncology Institute of Southern Switzerland (IOSI), Ospedale San Giovanni, Bellinzona, Switzerland PubMed articles Google scholar articles
K Yonemori National Cancer Center Hospital, Chuo-ku, Department of Breast and Medical Oncology, Tokyo, Japan PubMed articles Google scholar articles
S Banerjee The Royal Marsden NHS Foundation Trust, London, UK The Institute of Cancer Research, London, UK PubMed articles Google scholar articles
A Leary Gustave Roussy Cancer Campus, Villejuif, France GINECO, Villejuif, France PubMed articles Google scholar articles
X Mu Pfizer, San Diego, USA PubMed articles Google scholar articles
Y Liu Pfizer, San Diego, USA PubMed articles Google scholar articles
K Ching Pfizer, San Diego, USA PubMed articles Google scholar articles
S Deng Pfizer, San Diego, USA PubMed articles Google scholar articles
J Perkins Smith Pfizer Inc, New York, USA PubMed articles Google scholar articles
A Donahue Pfizer, San Diego, USA PubMed articles Google scholar articles
K Fujiwara Saitama Medical University International Medical Center, Hidaka, Saitama, Japan PubMed articles Google scholar articles
B Monk Arizona Oncology (US Oncology Network), Phoenix, USA University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, USA PubMed articles Google scholar articles

Citation

Pujade-Lauraine E, Ledermann J, Oza A, et al

229 Avelumab combined with pegylated liposomal doxorubicin in platinum-resistant/refractory ovarian cancer: biomarker analyses from JAVELIN Ovarian 200

International Journal of Gynecologic Cancer 2021;31:A210-A211.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password